Search Lavipharm.com

 

2019

 Peania, December 13th 2019 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to its Executive Chairman, Mr. Athanasios Lavidas,...

 Peania, November 29th 2019 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.'s Executive Chairman, Mr. Athanasios...

Lavipharm S.A. announces that, as of September 6th  2019, Mr. Antonis Vogiatzis, who held the position of General Manager, is no longer with the company....

  Peania, March 4th 2019 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, on February 28th 2019, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm SA's...

  Peania, March 7th 2019 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, on March 4th 2019, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm SA's...

  Peania, March 14, 2019 - Lavipharm S.A., pursuant to article 17 of the European Parliament and Council Regulation 596/2014 (EU) and its Board of Directors meeting held on 11.03.2019, hereby notifies the investor community that it will participate to the share capital increase amounting to...